The year 2026 began with a scenario that epidemiologists had been anticipating for years: the convergence of emerging infectious outbreaks, rising antibiotic-resistant bacteria, and persistent inequality in the distribution of essential medicines. Global public health, that network of national systems, international organizations, and supply chains, faces a relentless stress test.
The World Health Organization estimates that 10 million people could die each year by 2050 due to antimicrobial resistance if urgent action is not taken.
Epidemics Without Borders
In recent months, several countries have recorded unusual increases in diseases such as dengue, cholera, and new strains of avian flu. Climate change expands the habitat of mosquito vectors, while armed conflicts and mass displacements weaken drinking water and sanitation systems. Epidemiological surveillance, based on laboratory networks and early warning systems, has become the first line of defense, but its coverage remains uneven.
The Medicine Bottleneck
Although science advances by leaps and bounds—with gene therapies, mRNA vaccines, and new antivirals—access to these breakthroughs remains a privilege. Low- and middle-income countries often lack the infrastructure to store vaccines requiring ultra-cold chains or cannot afford treatments considered standard in the global North. Local production of generic drugs and technology transfer are recurring themes at international summits, but concrete progress is slow.
Antimicrobial Resistance
The ability of bacteria, viruses, and parasites to survive drugs designed to eliminate them. It is accelerated by the overuse of antibiotics in humans and animals and threatens to leave common infections untreated.
Surveillance, Privacy, and Trust
The COVID-19 pandemic taught that mass epidemiological surveillance—with tracking apps, mass testing, and genomic sequencing—can contain outbreaks but also creates tensions over privacy and data use. Today, several countries are updating their legal frameworks to balance public health with individual rights. Public trust, fragile after years of misinformation, is as valuable a resource as any vaccine.
What Does This Mean for the World?
Global public health is not just a matter for doctors and laboratories: it is a mirror of planetary inequalities. Investing in robust surveillance systems, local medicine production, and international cooperation is not an expense but an investment in stability. Every uncontained outbreak in a remote region can become the next global emergency. The challenge is not only scientific but political and ethical.